Literature DB >> 8310180

Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: comparison with other clostridial neurotoxins.

A Willems1, A K East, P A Lawson, M D Collins.   

Abstract

The neurotoxin gene from a strain of Clostridium botulinum type A causing infant botulism was cloned as a series of overlapping polymerase chain reaction (PCR) fragments generated using primers designed to conserved regions of published botulinal toxin (BoNT) sequences. Translation of the nucleotide sequence derived from cloned PCR fragments demonstrated that the toxin gene encodes a protein of 1,296 amino acid residues. Comparative alignment of the derived infant BoNT/A sequence with those of other published neurotoxins revealed highest sequence relatedness with BoNT/A of classical food-borne botulism. The sequence identity between infant and classical BoNT/A was 94.9% for the light chain (corresponding to 23 amino acid changes) and 87.1% for the heavy chain (corresponding to 109 amino acid changes).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8310180     DOI: 10.1016/0923-2508(93)90004-l

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  11 in total

1.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Quantification of Clostridium botulinum toxin gene expression by competitive reverse transcription-PCR.

Authors:  S McGrath; J S Dooley; R W Haylock
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

5.  First report of an infant botulism case due to Clostridium botulinum type Af.

Authors:  Laura I T de Jong; Rafael A Fernández; Virtudes Pareja; Gabriel Giaroli; Sergio R Guidarelli; Janet K Dykes; Carolina Lúquez
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

6.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

7.  Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.

Authors:  Regina C M Whitemarsh; William H Tepp; Marite Bradshaw; Guangyun Lin; Christina L Pier; Jacob M Scherf; Eric A Johnson; Sabine Pellett
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

Review 8.  Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature.

Authors:  Michael W Peck; Theresa J Smith; Fabrizio Anniballi; John W Austin; Luca Bano; Marite Bradshaw; Paula Cuervo; Luisa W Cheng; Yagmur Derman; Brigitte G Dorner; Audrey Fisher; Karen K Hill; Suzanne R Kalb; Hannu Korkeala; Miia Lindström; Florigio Lista; Carolina Lúquez; Christelle Mazuet; Marco Pirazzini; Michel R Popoff; Ornella Rossetto; Andreas Rummel; Dorothea Sesardic; Bal Ram Singh; Sandra C Stringer
Journal:  Toxins (Basel)       Date:  2017-01-18       Impact factor: 4.546

9.  Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins.

Authors:  Toshiaki Takeuchi; Tsuyoshi Okuno; Ai Miyashiro; Tomoko Kohda; Ryosuke Miyamoto; Yuishin Izumi; Shunji Kozaki; Ryuji Kaji
Journal:  Toxins (Basel)       Date:  2021-11-22       Impact factor: 4.546

10.  Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells.

Authors:  Regina Clare Meyer Whitemarsh; William Howard Tepp; Eric Arthur Johnson; Sabine Pellett
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.